SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-09-023538
Filing Date
2009-10-20
Accepted
2009-10-19 19:57:19
Documents
8
Period of Report
2009-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS INC 8-K 10-19-2009 form8k.htm 8-K 45854
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 148291
3 EXHIBIT 4.1 ex4_1.htm EX-4.1 106296
4 EXHIBIT 5.1 ex5_1.htm EX-5.1 15548
5 EXHIBIT 10.1 ex10_1.htm EX-10.1 207040
6 EXHIBIT 99.1 ex99_1.htm EX-99.1 12514
7 LOGO logo.jpg GRAPHIC 3162
8 LOGO 2 logo2.jpg GRAPHIC 4490
  Complete submission text file 0001140361-09-023538.txt   547968
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 091126814
SIC: 2834 Pharmaceutical Preparations